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Ablation for atrioventricular nodal reentry tachycardia is very effective, with a potential for damage to the normal conduction system. Cryoa-
blation is an alternative, as it allows cryomapping, which permits assessment of slow pathway elimination at innocent freezing temperatures,
avoiding permanent damage to the normal conduction system. It is associated with shorter radiation times and the absence of heart block in
all published data. We discuss in this overview different approaches of cryoenergy delivery (focusing on spot catheter ablation), and how
lesion formation is inﬂuenced by catheter tip size, application duration, and freezing rate. Some advantages of cryoenergy are explained.
Whether these features also apply for an approach with a cryoballoon, e.g. for atrial ﬁbrillation is unclear.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
In the past decade, a signiﬁcant amount of basic and clinical
research has been conducted regarding the use of cryoablation.
The different clinical trials leave no doubt on the advantageous
safety proﬁle of this ablation technique, with not a single perma-
nent heart block reported till now for atrioventricular nodal reen-
trant tachycardia (AVNRT).
1–4 This has lead to the use of
cryoablation as the technique of choice in medical or health care
environments where safety is the primary concern, e.g. in pediatric
patients, or when ablation is performed close to normal conduc-
tion system.
5 Still, some debate remains about the long-term efﬁ-
cacy of cryoablation. Table 1 shows the average success rate and
the long-term outcome of studies analysing cryoablation versus
radiofrequency (RF) in AVNRT. Acute success is similar, but it
cannot be denied that slightly more recurrences are observed
with cryotherapy.
1,2,5–10 However, it is possible that cryoablation
procedures can be improved. Issues such as catheter tip size, appli-
cation duration, and the temperature constant will be discussed in
this paper. In Table 2, we show procedure and radiation times as
reported by investigators, directly comparing cryoenergy, and RF,
clearly demonstrating that less ﬂuoroscopy is needed with
AVNRT, with a similar procedure time as for RF.
Lesion formation
The creation of a permanent cryolesion is characterized by three
phases: (i) the freeze/thaw phase, (ii) the haemorrhagic and inﬂam-
matory phase, and (iii) the replacement of this acute lesion by
ﬁbrosis.
11 In the ﬁrst phase, intracellular and extracellular ice crys-
tals are formed with variable size. Ice crystals formed more closely
to the catheter tip are intra- and extracellular, in contrast to more
peripheral ice crystals, which tend to appear only in the extracellu-
lar space. During the thawing phase, mitochondria develop
irreversible damage due to increased membrane permeability.
These changes are less marked towards the periphery.
12 The
second phase, occurring within the ﬁrst 48 h, is characterized by
the development of haemorrhage, oedema, and inﬂammation.
12,13
After 1 week, a sharply demarcated lesion is formed.
12 The ﬁnal
phase of lesion formation takes place within 2–4 weeks. At this
time, the lesion consists of dense collagen and is inﬁltrated
by fatty tissue. At its border many small blood vessels are found.
* Corresponding author. Tel: +31 10 463 2699; Fax: +31 10 463 2701, E-mail: l.jordaens@erasmusmc.nl
Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2010. For permissions please email: journals.permissions@oxfordjournals.org.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article
for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the
original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this
must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org.
Europace (2010) 12, 1522–1525
doi:10.1093/europace/euq294At 1 month, the lesion is composed of dense ﬁbrosis.
14 In
summary, cryolesions are formed by consecutive freezing, inﬂam-
mation, and ﬁbrosis, leading to tissue with intact extracellular
matrix. The advantage of preservation the endothelium is a
decreased risk of thromboembolism.
11 A theoretical advantage
could be that cryolesions are less proarrhythmic as the lesion is
more homogeneous.
At this moment, cryoenergy is applied at the epicardium by sur-
geons and by spot, and balloon catheters by the cardiologist. It is
evident that these methods will result in different ways of lesion
formation. Most of what we will address in this review will be
based on data from spot catheters, as used for AVNRT.
Cryomapping
One of the major advantages of cryoablation is the possibility of
cryomapping, a feature which was initially introduced by
Dubuc.
15 After cryoadhesion at 2308C, freezing is continued at
this temperature, to evaluate the clinical effect of the application,
and to proof that no collateral damage is present. Some authors
reported that temporary AV block may happen, even after such
cautious approach.
16,17 Nevertheless, this should not lead to per-
sisting block. Even fast freezing till 2708C on the target site was
applied to perform cryomapping, and did not lead to permanent
block in the hand of other investigators.
6 However, it has to be
pointed out that this ‘aggressive’ approach was associated with a
lower procedural success than for other groups, with substantially
more recurrences (Table 1). One of the reasons might be that
the ‘stunned’ area becomes larger, and that real (i.e. long-term)
success becomes more difﬁcult to predict. More moderate
attempts, using 2408C resulted as well in local damage.
18
Catheter tip size
Catheter tip size can be a very important determinant of pro-
cedural success. Nowadays, 4, 6, and 8 mm tip catheters are avail-
able. In everyday practice, the 4 and 6 mm tip catheters are used
most frequently for treating AVNRT, although the 8 mm tip cath-
eter can be very useful in other areas as ventricular tachycardia,
Wolff–Parkinson–White (WPW), and atrial ﬂutter.
19 The 4 and
6 mm tip catheters create a lesion size, which is smaller than the
lesions of the 8 mm tip.
12 The difference seems to be mostly
dependent on the angle of the catheter tip in relation to the
surface.
20 Moreover, when comparing the 4 and 6 mm tip cath-
eters in AVNRT in clinical practice (Table 3), there seems to be
a difference in efﬁcacy in favour of the 6 mm tip catheters: acute
success is similar in both groups, but there is a higher recurrence
rate in the 4 mm tip group.
21,22
Apart from the lesion size and depth, lesion quality or degree of
tissue damage created by cryoablation is inﬂuenced by the selected
catheter tip size and by the tissue contact reached during the abla-
tion, as shown in the recent experimental paper of Atienza et al.
23
Application duration
It was shown in several experimental settings that lesion depth is
determined by the duration of freezing. During the ﬁrst minute a
stable temperature gradient is reached, and a plateau phase is
................................ ............................... ..............................
...............................................................................................................................................................................
Table 1 Acute procedural and long-term outcome data in studies comparing cryothermy vs. radiofrequency
Authors Patient nr Acute success (%) Recurrences (%)
Cryo RF Cryo RF Cryo RF
Kimman et al.
1 30 33 93 91 10 9
Zrenner et al.
2 100 100 97 98 8 1
Gupta et al.
6 71 71 85 97 19.8 5.6
Collins et al.
5 57 60 95 100 8 2
Avari et al.
7 38 42 97 95 2 2
Chan et al.
8 80 80 97.5 95 9 1.3
Schwagten et al.
9 144 130 97 95 7.5 6.5
Opel et al.
10 123 149 83 93 11 3
Total 643 665 93 96 10 4.2
Cryo, cryothermy; RF, radiofrequency
..................... ....................
................................................................................
Table 2 Comparison of procedural parameters in
studies using cryothermy vs. radiofrequency
Authors Procedure time
(min)
Fluoroscopy
time (min)
Cryo RF Cryo RF
Kimman et al.
1 142,5 144 29 35
Zrenner et al.
2 140 112 12 14
Gupta et al.
6 96 90 17 13
Collins et al.
5 146 112 20 21
Avari et al.
7 176 174 19 21
Chan et al.
8 150 159 19 26
Schwagten et al.
9 149 152 22 29
Opel et al.
10 90 90 16 14
Cryo, cryothermy; RF, radiofrequency.
Medians are in bold, italic; means are in a regular font.
How to improve results in AVNRT ablation? 1523achieved at 5–6 min.
11,13,21 This is reﬂected in most clinical set-
tings, where cryoenergy is applied for 4–5 min.
A recent experimental paper describing the electrophysiologic
and histologic changes in correlation to the duration of the cryoap-
plication using an 8 mm tip catheteron the compact AV node in pigs
showedthatrecoveryofAVnodalfunctionwaslesslikelyiftheappli-
cation lasted longer.
23 They observed that isolated viable cells sur-
rounded by necrotic tissue in the compact AV node were
associated with acute AV conduction recovery. Moreover, they wit-
nessed a variation in the degree of myolytic changes between the
animals with and without persistent AV block at 1 week.
Somesuggestionshavebeenmadetoimprovelesionformationby
applyingadoublefreezingcycle(freezing–thawing–freezing).
24First,
a freezing phase of 4 min is applied. Then the catheter rewarms and
immediately a new freezing cycle is performed at exactly the same
site for 2 min. Data in hepatocellular ablation show that repetitive
freeze–thaw cycles create larger lesions than those obtained by
longerfreezingatacertaintemperature.
25Therateandextentofcon-
duction of the cold front increases with repetitive exposure, what
suggests a progressive increase in thermal conductivity of tissue.
Although poorly understood, this could be related to basic cellular
structure changes and/or modiﬁcation of local microperfusion.
26 So
far, no cardiovascular data exist to support the routine use of this
technique, which was tested in hepatic disorders.
Temperature time constant
Severalsuggestionshavealreadybeenmadetoimprovethequalityof
the lesion. Fast freezing, with a steep decrease in temperature is
moreeffectivethanaslowprogressiontothetargettemperatures.
27
It was demonstrated in a group of WPW patientsthat successful ice
mappingattemptswerecharacterizedbyashorttime-constant.This
parameter reﬂects the time interval between the onset of ice
mapping and the steady-state mapping temperature of 2308C.
Catheter adhesion
The formation of ice during ablation at the tip of the catheter
causes the catheter to adhere to the adjacent tissue
(cryoadherence). This allows pacing manoeuvres in the atrium
and the ventricle during ablation without the risk of catheter dis-
lodgement, what is very useful to show persistence or absence
of slow pathway conduction. Moreover, ablation can be performed
during tachycardia without a risk of dislodging the catheter when
normal rhythm is restored. Also, small patient movements and
even deep breaths do not affect ablation catheter position during
ablation. Unlike the ‘brush lesions’ formed by radiofrequency abla-
tion, cryoablation creates very focal lesions. This is similar to
lesions as described with magnetic navigation.
28
Recurrence
It is not impossible that some of the recurrences are due to recon-
duction, a phenomenon which is well known in the pulmonary
veins, where reconnection is often detected, and almost always
when a patient is restudied because of recurrences.
29 Asympto-
matic reconduction is also seen in a recent study on cryoablation
of the cavotricuspid isthmus in 23% of cases during restudy after
several weeks.
30 This might be a reason to strictly adhere to
some observation time after ablation, and to ascertain that there
is no more slow pathway conduction after this time.
Conclusion
In conclusion, cryoablation is a safe and effective approach for
AVNRT, but care should be taken to use it in a way with full under-
standing of its possibilities and limitations, otherwise it could lead
to disappointing results.
This means that cryomapping should be performed to demon-
strate that the catheter is over the slow pathway, which is imposs-
ible with RF techniques. Further, application times should be long
enough to create full lesions. A 6 mm tip is probably better than
the 4 mm tip, which still may have a place in some pediatric indi-
cations. Energy sources should allow very fast freezing to
improve penetration of the cold in the tissue. Finally, waiting
times should be respected, as recovery within a short time may
indicate that more applications are necessary. In this way, cryoabla-
tion is an elegant technique, with few important side effects. The
...............................................................................................................................................................................
Table 3 Comparison of procedural and outcome data in studies comparing 4 and 6 mm tips for slow pathway ablation
Authors Nr of cryoablation
patients
Study design Acute
success
Follow-up
(months)
Recurrences Temporary
AV block
(ﬁrst, second,
third)
Complete,
permanent
AV block
De Sisti et al.
17 8 (4 mm) SC, cohort, prospective,
4 and 6 mm
4/8 18
a 4/4 NR (21/69) 0
61 (8 mm) 56/61 20/59 0
Sandilands et al.
21 59 (4 mm) SC, cohort, prospective,
4v s6m m
54/59 18
a 12/54 NR (13/160) 0
101 (6 mm) 95/101 7/95 0
Rivard et al. (2007)
31 152 (4 mm) SC, 2 cohort, retrospective,
4v s6m m
139/152 6 22/139 6/152 0
137 (6 mm) 123/137 4.7 10/123 12/137 0
NR, not reported; SC, single centre.
aSubgroup not speciﬁed.
B. Schwagten et al. 1524complete absence of AV nodal conduction defects in AVNRT,
should make it a strategy of ﬁrst choice. The small excess
number of patients requiring a second approach makes the extra
amount of radiation and catheterization related complications of
a second procedure acceptable, due to the absence of the main
RF related complication. Further studies should be undertaken to
improve the long-term outcome, as the value of freeze–thaw–
freeze cycles and different application times; more ﬂexible cath-
eters, e.g. steerable with robotics or magnetic navigation (and
without pull wires) could make the procedure even more safe.
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